Price
No data yet.
Social Signal Score
Analyst Ratings
16 analystsRevenue
$464.11M+33.92%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Payman Khales
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 11,000
- Beta
- 0.61
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.85
Financials
Revenue
$464.11M+33.9%Net Income
$23.61M+106.0%EBITDA
$67.96M-6.7%Free Cash Flow
$37.04M+72.5%EPS (diluted)
$0.69+86.5%Shares Outstanding (diluted)
34.15M+9.6%Operating Expenses
$68.98MCash & Debt
$21.38MReturn of Capital
$0.00Revenue by Segment (annual)
$1.85BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.85B | $102.76M | $2.96 |
| 2024 | $1.72B | $119.90M | $3.60 |
| 2023 | $1.56B | $90.65M | $2.72 |
| 2022 | $1.33B | $66.38M | $1.97 |
| 2021 | $1.22B | $96.81M | $2.82 |
| 2020 | $1.07B | $77.26M | $2.35 |
| 2019 | $1.26B | $96.34M | $2.80 |
| 2018 | $1.22B | $167.96M | $5.23 |
| 2017 | $1.14B | $66.68M | $2.12 |
| 2016 | $1.08B | $5.96M | $0.19 |
| 2015 | $800.41M | $-7.59M | $-0.29 |
| 2014 | $687.79M | $55.46M | $2.23 |
| 2013 | $663.95M | $36.27M | $1.51 |
| 2012 | $646.18M | $-4.80M | $-0.20 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $4.35
- Implied price
- $113.02
- Return from $126.45
- -2.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $56.19 — -55.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 18 | 22 | 26 | 30 | 34 |
|---|---|---|---|---|---|
| -2.0% | -17.6% | -14.2% | -11.3% | -8.7% | -6.4% |
| 3.0% | -13.4% | -9.8% | -6.7% | -4.0% | -1.6% |
| 8.0% | -9.2% | -5.4% | -2.2% | 0.6% | 3.2% |
| 13.0% | -4.9% | -1.1% | 2.3% | 5.3% | 7.9% |
| 18.0% | -0.7% | 3.3% | 6.8% | 9.9% | 12.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
150+114.29%Social Signal Score
Mentions (10)
- News (RSS)investing·3d ago·Neutral
Integer noteholders can convert bonds through December 31
View source ↗ - Newsglobenewswire.com·3d ago·Neutral
…poration Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the …
View source ↗ - Newsglobenewswire.com·6d ago·Neutral
…y Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR PLANO, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract development and manufacturing organization (CDMO), today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with the previously announced a…
View source ↗ - Newszacks.com·6d ago·Neutral
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio ITGR's $127-a-share KKR deal offers defined cash value, while core franchises face slow new-product adoption.
View source ↗ - News (RSS)investing·24d ago·Neutral
KKR finalizes $2.1 billion loan to fund Integer acquisition
View source ↗ - Newsglobenewswire.com·26d ago·Negative
ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR) for potential breaches of fiduciary duty on the part of its directors and management.
View source ↗ - Newsbusinesswire.com·30d ago·Neutral
ITGR Stock Alert: Halper Sadeh LLC is Investigating Whether Integer Holdings Corporation is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Integer Holdings Corporation (NYSE: ITGR) to KKR for $127.00 per share.Halper Sadeh encourages Integer shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@ha…
View source ↗ - Newsbusinesswire.com·34d ago·Neutral
Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR LOS ANGELES--(BUSINESS WIRE)---- $ITGR--Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR.
View source ↗ - Newsbusinesswire.com·43d ago·Negative
ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $ITGR--ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law.
View source ↗ - Newszacks.com·56d ago·Positive
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.
View source ↗
Earnings
Thu, Oct 22(in 2 weeks)
Consensus estimate $1.68 per share
Typical surprise +3.1% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$1.60 vs $1.38beat
- Thu, Apr 30$1.20 vs $1.21miss
- Thu, Feb 19$1.76 vs $1.70beat
- Thu, Oct 23$1.79 vs $1.68beat
- Thu, Jul 24$1.55 vs $1.57miss
- Thu, Apr 24$1.31 vs $1.27beat
Estimates and results for ITGR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ITGR officers and directors.
- Bought
- —
- Sold
- $5.2m
0 trades
4 trades
- Thor Kirk Ksold
- Thor Kirk Ksold
- Senn Andrewsold
- Thomas Tommy Psold
96 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ITGR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.